Trial Profile
Non-Interventional Observational Study to Evaluate Change of PSA Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide in Combination With Medical or Surgical Castration.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 16 Apr 2010 Actual patient number (340) added as reported by ClinicalTrials.gov.
- 16 Apr 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
- 16 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.